Affordable Access

Publisher Website

Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway.

Authors
Type
Published Article
Journal
Annals of the Rheumatic Diseases
1468-2060
Publisher
BMJ
Publication Date
Volume
70
Issue
11
Pages
2029–2036
Identifiers
DOI: 10.1136/ard.2011.150326
PMID: 21803750
Source
Medline

Abstract

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments